Results 251 to 260 of about 1,251,677 (333)

Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer. [PDF]

Oncol Lett
Maehana T, Kawaguchi R, Nishikawa K, Kawahara N, Yamada Y, Kimura F.   +5 more
europepmc   +1 more source

Research progress on the metabolic transformation of Shenling Baizhu San under the influence of the gut microbiota

Advanced Chinese Medicine, EarlyView.
Abstract The gut microbiota plays a pivotal role in maintaining host metabolic homeostasis and overall physiological functions. Shenling Baizhu San (SLBZS), a time‐honored classical prescription for tonifying Qi, strengthening the spleen, removing dampness, and arresting diarrhea, has shown broad clinical efficacy in digestive disorders.
Jinlan Di, Xiaochun Zhang
wiley   +1 more source

Tissue factor pathway inhibitor is required for cerebrovascular development in mice.

Blood, 2021
Maroney SA, Westrick RJ, Cleuren AC, Martinez ND, Siebert AE, Zogg M, Ginsburg D, Weiler H, Mast AE.   +8 more
europepmc   +1 more source

MG1113, a specific anti-tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia. [PDF]

Res Pract Thromb Haemost, 2020
Kwak H, Lee S, Jo S, Kwon YE, Kang H, Choi G, Jung ME, Kwak MJ, Kim S, Oh BH, Kim DS, Hwang SH.   +11 more
europepmc   +1 more source

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.

Proceedings of the National Academy of Sciences of the United States of America, 1994
C. Sprecher, Walter Kisiel, S. Mathewes, Donald C. Foster   +3 more
semanticscholar   +1 more source

Progress of research on delaying bone destruction of rheumatoid arthritis by combining traditional Chinese and Western medicine

Advanced Chinese Medicine, EarlyView.
Abstract Rheumatoid arthritis (RA) is a common autoimmune disease with bone destruction as the core pathology, which belongs to the category of “impediment disease” in traditional Chinese medicine (TCM), and its etiology and pathogenesis are still not completely clear.
Dier Jin, Yuanyuan Xu, Wenwen Qi, Tianyi Lan, Ting Liu, Rihong Liu, Zihan Wang, Yuan Xu   +7 more
wiley   +1 more source

Effect of tissue factor pathway inhibitor on the pyroptosis of vascular smooth muscle cells induced by angiotensin II. [PDF]

Cardiovasc Diagn Ther
Dai Y, Xu R, Yang K, Jiang T, Wei Y, Liu Y, Chen W, Fu Y, Zhao Y.   +8 more
europepmc   +1 more source

Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite celecoxib, a cyclooxygenase‐2 inhibitor, promoting functional recovery from intracerebral hemorrhage (ICH) by reducing inflammation‐mediated perihematomal edema in rat models, the evidence of its effects on patient outcomes remains limited.
Shin‐Joe Yeh, Sung‐Chun Tang, Li‐Kai Tsai, Jiann‐Shing Jeng   +3 more
wiley   +1 more source

Curcumin reactivates epigenetically silenced tumor suppressor gene tissue factor pathway inhibitor-2 in hepatocellular carcinoma cells.

, 2010
Akshata Moghe
openalex   +2 more sources

Acadesine Inhibits Tissue Factor Induction and Thrombus Formation by Activating the Phosphoinositide 3-Kinase/Akt Signaling Pathway [PDF]

, 2010
Weiyu Zhang, Jianguo Wang, Huan Wang, Rong Tang, John D. Belcher, Benoı̂t Viollet, Jian-Guo Geng, Chunxiang Zhang, Chaodong Wu, Arne Slungaard, Chuhong Zhu, Yuqing Huo   +11 more
openalex   +1 more source